Pharmacytimes: Condition Center: CNS CNS en-us Sun, 18 Mar 2018 03:36:38 UTC Sun, 18 Mar 2018 03:36:38 UTC Let's Talk About Multiple Sclerosis <hr />March is MS awareness month, spotlighting this chronic, progressive disease that is growing in prevalence. 8:00 AM, Thu March 1, 2018 8 Multiple Sclerosis Studies Pharmacists Should Know About, Part 1 A number of landmark clinical studies in the field of MS have been published, shaping how the disease is treated. 3:15 AM, Thu January 18, 2018 Perspectives for the Pharmacist in Epilepsy Management: Considerations for the Use of FYCOMPA(R) (perampanel) Tablets and Oral Suspension, CIII 10:27 AM, Wed September 13, 2017 Amino Acid L-Serine in Preventing Neurodegenerative Diseases Associated with BMAA Insights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins. 9:41 PM, Mon September 4, 2017 CDC: Epilepsy Rates Increasing Among Adults, Children For the first time, epilepsy rate estimates have been available for every state, totaling in at least 3.4 million individuals living with the disorder. 10:51 AM, Wed August 23, 2017 Epileptic Patients Face Heightened Suicide Risk Patients with epilepsy are more likely to commit suicide than individuals without the condition, according to the results of a recent CDC study. 3:47 PM, Mon March 20, 2017 Antipsychotic Drugs Could Increase Mortality in Parkinson's Disease Patients Antipsychotic medications may do more harm than good in patients with Parkinson&rsquo;s disease, with a recent study indicating that the use of these drugs can lead to a heightened mortality risk in this population. 3:47 PM, Mon March 20, 2017 Early Treatment of MS Signs May Slow Disease Progression A recent study has suggested that starting patients on multiple sclerosis medication soon after they show initial signs of the disease could prolong the time before the condition becomes fully diagnosable. 3:47 PM, Mon March 20, 2017 Epilepsy: What You and Your Patients Need to Know The year 2016 was big for neurology, particularly in the realm of epilepsy. 1:08 PM, Mon March 20, 2017 Self-Care for Central Nervous System Function Which OTC products should these pharmacists recommend? 12:03 PM, Mon March 20, 2017 What Role Do Zebrafish Models Play in Epilepsy Treatment? Scientists have discovered a potential new drug therapy by using a zebrafish model of epilepsy.&nbsp; 9:00 AM, Tue February 14, 2017 Eisai Begins 2 Phase 3 Trials to Further Assess FYCOMPA Eisai announced the beginning of 2 multi-center, global phase 3 clinical trials&nbsp;assessing FYCOMPA (perampanel). 7:00 AM, Wed November 2, 2016 A Brief Review of Brand-Name Antiepileptic Drugs Epilepsy is a brain disorder that predisposes an individual to recurrent unprovoked seizures. 4:17 AM, Wed May 18, 2016 New Fycompa Oral Suspension Formulation Receives FDA Approval Initially approved in tablet form in 2012, perampanel (Fycompa) is now available as an oral suspension. 10:04 PM, Tue May 17, 2016 Self-Care for Disorders Related to the Central Nervous System Which OTC products should these pharmacists recommend? 10:30 PM, Mon March 14, 2016 More Women with Epilepsy Should Consider Contraceptives Because many antiepileptic drugs have teratogenic potential, health care providers commonly recommend contraceptives to women with epilepsy. 9:37 PM, Mon March 7, 2016 FDA Approves New Epileptic Seizure Treatment The FDA has approved UCB's brivaracetam (Briviact) as an adjunctive treatment for partial-onset seizures in patients aged 16 years and older with epilepsy. 12:32 AM, Fri February 19, 2016 3 Things Pharmacists Should Know About Neglected Tropical Diseases Since many neglected tropical diseases never appear in pharmacy school textbooks, here are some things you need to know about them. 3:31 AM, Mon January 11, 2016 Top 5 Natural Epilepsy Treatments Pharmacists can help patients take a big step towards managing their epilepsy by identifying epileptic triggers. 8:30 PM, Tue December 22, 2015 Epilepsy Treatment Should Immediately Follow First Seizure A guideline recently released by the American Academy of Neurology and the American Epilepsy Society has clarified that antiepileptic medication should be administered immediately after a patient's first seizure in order to reduce the risk of having another seizure within 2 years. 4:00 AM, Mon December 21, 2015